Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||
net income | 31,805,000 | 5,607,000 | -2,447,000 | -2,755,000 | -6,758,000 | -54,470,000 | -64,598,000 | -42,398,000 | -40,315,000 | -28,165,000 | -129,254,000 | -56,223,000 | -29,871,000 | 32,692,000 | |||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||
change in fair value of loans | -62,384,000 | -28,126,000 | 7,062,000 | -42,543,000 | 63,767,000 | 49,761,000 | 54,017,000 | ||||||||||||
change in fair value of servicing assets | 4,155,000 | 4,550,000 | 4,090,000 | 3,652,000 | 4,637,000 | 3,915,000 | 4,286,000 | ||||||||||||
change in fair value of servicing liabilities | -386,000 | -338,000 | -285,000 | -369,000 | -60,000 | -363,000 | -454,000 | ||||||||||||
change in fair value of beneficial interest assets | 7,279,000 | -5,884,000 | -17,600,000 | 40,976,000 | -34,758,000 | 3,414,000 | -4,481,000 | ||||||||||||
change in fair value of beneficial interest liabilities | 6,706,000 | 12,172,000 | -65,000 | -65,000 | 3,289,000 | 4,371,000 | 4,973,000 | ||||||||||||
change in fair value of other financial instruments | -3,145,000 | -2,351,000 | -33,000 | -4,133,000 | 12,579,000 | -5,867,000 | 1,551,000 | ||||||||||||
stock-based compensation | 34,155,000 | 35,511,000 | 29,831,000 | 29,796,000 | 33,618,000 | 34,209,000 | 35,777,000 | 32,766,000 | 35,568,000 | 32,596,000 | 74,109,000 | 33,910,000 | 36,656,000 | 30,329,000 | 25,050,000 | 23,061,000 | 20,317,000 | 21,186,000 | 8,622,000 |
gain on loan servicing rights | -7,925,000 | -7,506,000 | -4,945,000 | -4,001,000 | -5,551,000 | -2,951,000 | -2,946,000 | ||||||||||||
gain on debt extinguishment | 0 | ||||||||||||||||||
depreciation and amortization | 6,131,000 | 5,843,000 | 6,400,000 | 4,699,000 | 5,390,000 | 4,828,000 | 5,632,000 | 9,103,000 | 4,934,000 | 4,425,000 | 6,441,000 | 3,654,000 | 3,724,000 | 3,354,000 | 2,781,000 | 2,557,000 | 2,185,000 | 1,983,000 | 816,000 |
loan premium amortization | -14,384,000 | -10,824,000 | -8,352,000 | ||||||||||||||||
non-cash interest expense and other | 2,216,000 | 1,678,000 | 1,325,000 | ||||||||||||||||
net changes in operating assets and liabilities: | |||||||||||||||||||
purchases of loans held-for-sale | -2,440,455,000 | -2,624,546,000 | -1,345,253,000 | -1,683,022,000 | -1,056,233,000 | -773,470,000 | -796,543,000 | ||||||||||||
proceeds from sale of loans held-for-sale | 2,270,958,000 | 2,407,037,000 | 1,316,696,000 | 1,488,898,000 | 1,121,045,000 | 719,304,000 | 772,690,000 | 639,269,000 | 608,754,000 | 817,265,000 | 449,339,000 | 5,973,626,000 | 220,392,000 | 583,835,000 | 50,764,000 | ||||
principal payments received for loans held-for-sale | 55,407,000 | 44,886,000 | 38,252,000 | 35,879,000 | 41,675,000 | 62,494,000 | 52,841,000 | 50,164,000 | 37,753,000 | 43,880,000 | 57,949,000 | 47,969,000 | 37,259,000 | 46,462,000 | 20,328,000 | 4,261,000 | 722,000 | 1,039,000 | 2,637,000 |
principal payments received for loans held by consolidated securitization | 9,839,000 | 9,653,000 | 10,280,000 | 11,465,000 | 11,818,000 | 12,376,000 | 12,338,000 | 12,530,000 | |||||||||||
settlements of beneficial interest liabilities | -4,052,000 | -5,672,000 | -5,992,000 | ||||||||||||||||
proceeds from beneficial interest assets | 3,290,000 | 75,000 | 731,000 | 9,122,000 | 1,079,000 | ||||||||||||||
settlements of beneficial interest assets | -636,000 | -538,000 | -485,000 | ||||||||||||||||
other assets | -239,000 | -2,373,000 | 6,437,000 | -6,580,000 | -7,832,000 | 6,547,000 | -825,000 | -8,959,000 | 3,853,000 | -4,132,000 | 306,000 | -4,546,000 | -4,477,000 | 5,909,000 | 7,287,000 | -39,236,000 | -3,155,000 | -9,663,000 | -9,988,000 |
operating lease liability and right-of-use asset | -308,000 | -304,000 | -306,000 | -207,000 | -200,000 | -198,000 | -202,000 | -8,385,000 | 125,000 | 222,000 | 1,216,000 | 2,509,000 | 2,430,000 | 2,681,000 | 2,584,000 | 2,098,000 | 580,000 | 214,000 | 234,000 |
accrued expenses and other liabilities | -13,410,000 | 41,288,000 | -48,827,000 | 25,478,000 | 31,775,000 | 12,717,000 | -25,846,000 | 15,692,000 | 4,350,000 | 1,284,000 | -19,155,000 | -5,806,000 | -535,000 | -13,866,000 | -11,093,000 | 29,722,000 | 6,069,000 | 19,184,000 | 4,601,000 |
net cash from operating activities | -122,629,000 | -120,162,000 | -13,486,000 | -110,926,000 | 179,340,000 | 65,295,000 | 52,622,000 | -143,712,000 | -103,433,000 | 162,379,000 | -75,727,000 | -252,877,000 | -101,366,000 | -53,643,000 | -266,795,000 | -11,144,000 | 43,601,000 | 92,804,000 | 43,092,000 |
capex | -3,963,000 | -4,251,000 | -6,159,000 | -3,419,000 | -2,494,000 | -2,328,000 | -1,749,000 | -1,424,000 | -2,946,000 | -2,016,000 | -5,458,000 | -4,983,000 | -5,523,000 | -7,120,000 | -5,287,000 | -5,683,000 | -5,287,000 | -3,544,000 | -601,000 |
free cash flows | -126,592,000 | -124,413,000 | -19,645,000 | -114,345,000 | 176,846,000 | 62,967,000 | 50,873,000 | -145,136,000 | -106,379,000 | 160,363,000 | -81,185,000 | -257,860,000 | -106,889,000 | -60,763,000 | -272,082,000 | -16,827,000 | 38,314,000 | 89,260,000 | 42,491,000 |
cash flows from investing activities | |||||||||||||||||||
purchases and originations of loans held-for-investment | -288,109,000 | -228,024,000 | -149,916,000 | -126,516,000 | -85,639,000 | -64,789,000 | -46,152,000 | ||||||||||||
proceeds from sale of loans held-for-investment | 30,948,000 | 18,600,000 | 1,647,000 | 198,000 | 2,296,000 | 11,910,000 | |||||||||||||
principal payments received for loans held-for-investment | 92,055,000 | 72,524,000 | 57,417,000 | 45,498,000 | 39,561,000 | 32,965,000 | 27,242,000 | 24,119,000 | 27,900,000 | 26,005,000 | 24,422,000 | 15,600,000 | 9,187,000 | 9,127,000 | 9,397,000 | 9,810,000 | 7,234,000 | 4,486,000 | 3,002,000 |
principal payments received for notes receivable and repayments of residual certificates | 6,374,000 | 3,836,000 | 2,685,000 | 1,913,000 | 1,323,000 | 1,456,000 | 1,225,000 | 772,000 | 560,000 | 1,430,000 | 1,566,000 | 1,228,000 | 1,596,000 | 1,845,000 | 2,067,000 | 2,343,000 | 2,766,000 | 3,230,000 | 3,119,000 |
acquisition and settlements of beneficial interest assets | |||||||||||||||||||
issuance of line of credit receivable | -57,701,000 | 24,983,000 | 24,856,000 | -23,873,000 | -22,646,000 | ||||||||||||||
repayments of line of credit receivable | |||||||||||||||||||
purchases of property and equipment | -75,000 | 0 | -116,000 | -37,000 | -684,000 | ||||||||||||||
capitalized software costs | -3,888,000 | -4,251,000 | -6,159,000 | -3,419,000 | -2,378,000 | -2,291,000 | -1,065,000 | -1,424,000 | -2,811,000 | -1,977,000 | -4,347,000 | -3,246,000 | -4,013,000 | -3,171,000 | -3,658,000 | -2,212,000 | -2,328,000 | -1,814,000 | -334,000 |
net cash from investing activities | -120,506,000 | -109,834,000 | -78,569,000 | -77,909,000 | -46,170,000 | -76,100,000 | -37,547,000 | -29,893,000 | -24,216,000 | -38,494,000 | -25,852,000 | -85,113,000 | -24,248,000 | -9,941,000 | 5,177,000 | -19,776,000 | -84,402,000 | -40,601,000 | 902,000 |
cash flows from financing activities | |||||||||||||||||||
proceeds from borrowings | 36,492,000 | 173,250,000 | 74,260,000 | 97,416,000 | 189,124,000 | 279,697,000 | 60,673,000 | 258,543,000 | 169,071,000 | 181,195,000 | 80,004,000 | 712,591,000 | 0 | 0 | 5,831,000 | ||||
proceeds from convertible notes issuance, net of debt issuance costs paid to lender | 490,438,000 | ||||||||||||||||||
payment of debt issuance costs to third parties | |||||||||||||||||||
repayments of borrowings | -54,803,000 | -44,824,000 | -110,175,000 | -61,145,000 | -117,148,000 | -350,682,000 | -46,962,000 | -191,819,000 | -107,466,000 | -94,623,000 | -6,990,000 | -5,904,000 | -2,957,000 | -35,871,000 | -26,584,000 | ||||
payments for repurchases of convertible notes | 0 | ||||||||||||||||||
purchase of capped calls | 0 | 0 | |||||||||||||||||
settlement of capped calls | 0 | ||||||||||||||||||
principal payments made on securitization notes | -10,002,000 | -10,577,000 | -11,444,000 | -12,663,000 | -14,259,000 | -14,882,000 | -13,564,000 | ||||||||||||
payable to investors | 1,731,000 | 8,555,000 | 22,941,000 | -605,000 | -4,724,000 | 10,821,000 | 6,893,000 | 1,930,000 | 5,917,000 | -1,106,000 | -49,730,000 | -3,067,000 | -11,868,000 | -34,090,000 | 32,204,000 | 23,286,000 | 7,365,000 | 20,457,000 | 10,989,000 |
proceeds from issuance of common stock under employee stock purchase plan | 3,757,000 | 0 | 4,692,000 | 0 | 3,120,000 | 0 | 4,565,000 | 0 | 2,703,000 | 0 | 5,728,000 | 0 | 3,231,000 | 0 | 4,431,000 | 0 | |||
proceeds from exercise of stock options | 4,628,000 | 1,657,000 | 8,209,000 | 9,133,000 | 10,062,000 | 1,015,000 | 1,204,000 | 3,406,000 | 2,803,000 | 5,135,000 | 1,537,000 | 1,628,000 | 1,319,000 | 3,781,000 | 5,626,000 | 4,963,000 | 6,841,000 | 1,440,000 | 1,492,000 |
taxes paid related to net share settlement of equity awards | -2,000 | -2,000 | -5,000 | -3,000 | -17,000 | -1,000 | -1,000 | -9,000 | 0 | -1,000 | -5,000 | -8,000 | 0 | 0 | |||||
net cash from financing activities | 378,580,000 | 91,928,000 | -44,680,000 | 509,331,000 | -38,021,000 | 132,272,000 | -43,711,000 | 26,364,000 | 232,784,000 | -65,851,000 | 20,971,000 | 40,531,000 | 41,119,000 | -34,689,000 | 83,071,000 | 50,400,000 | 595,029,000 | 229,264,000 | -19,261,000 |
change in cash, cash equivalents and restricted cash | 135,445,000 | -138,068,000 | -136,735,000 | ||||||||||||||||
cash, cash equivalents and restricted cash | |||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 0 | 0 | 976,263,000 | ||||||||||||||||
cash, cash equivalents and restricted cash at end of period | 135,445,000 | -138,068,000 | 839,528,000 | ||||||||||||||||
supplemental disclosures of cash flow information | |||||||||||||||||||
cash paid for interest | 12,404,000 | 14,732,000 | 7,378,000 | 8,324,000 | 10,285,000 | 12,047,000 | 12,463,000 | 14,066,000 | 10,241,000 | 4,281,000 | 7,959,000 | 4,521,000 | 3,876,000 | 2,313,000 | 1,763,000 | 478,000 | 269,000 | 1,497,000 | 1,030,000 |
cash paid for income taxes | 22,000 | 454,000 | 96,000 | 122,000 | 154,000 | 34,000 | 18,000 | 53,000 | 680,000 | ||||||||||
supplemental disclosures of non-cash investing and financing activities | |||||||||||||||||||
beneficial interests obtained in connection with loan sale | 108,640,000 | 71,431,000 | 38,133,000 | 44,594,000 | 32,416,000 | 0 | 13,555,000 | ||||||||||||
securities retained under unconsolidated securitization transactions | 27,525,000 | ||||||||||||||||||
capitalized stock-based compensation expense | 2,001,000 | 2,595,000 | 3,144,000 | 1,511,000 | 1,104,000 | 1,159,000 | 546,000 | 776,000 | 1,860,000 | 1,372,000 | 2,658,000 | 1,413,000 | 1,550,000 | 1,370,000 | 1,627,000 | 1,021,000 | 1,100,000 | 898,000 | 122,000 |
settlement of borrowings in connection with loan sale | 0 | 0 | |||||||||||||||||
acquisition of beneficial interest assets | 0 | -305,000 | -38,000 | 0 | -46,306,000 | -16,940,000 | |||||||||||||
payment of debt issuance costs to third party | 0 | -443,000 | -2,490,000 | ||||||||||||||||
payable to investors for beneficial interest assets | |||||||||||||||||||
proceeds from warehouse borrowings | 53,655,000 | 89,694,000 | |||||||||||||||||
repayments of warehouse borrowings | -122,285,000 | -64,173,000 | |||||||||||||||||
beneficial interest assets included in payable to investors | 4,400,000 | ||||||||||||||||||
payments on beneficial interest liabilities | -3,008,000 | -1,325,000 | -1,657,000 | -710,000 | |||||||||||||||
purchases of non-marketable equity securities | |||||||||||||||||||
purchase of certificates of deposit | |||||||||||||||||||
proceeds from issuance of securitization notes | 0 | ||||||||||||||||||
repurchases of common stock | -27,813,000 | -25,028,000 | |||||||||||||||||
cash, cash equivalents and restricted cash at beginning of year | |||||||||||||||||||
cash, cash equivalents and restricted cash at end of year | |||||||||||||||||||
cash (received) paid for income taxes | 8,000 | 37,000 | 125,000 | 88,000 | 324,000 | 7,000 | 164,000 | -1,153,000 | |||||||||||
securities retained under unconsolidated securitization transaction | |||||||||||||||||||
issuance costs of new convertible notes | 271,000 | ||||||||||||||||||
securities retained under consolidated securitization transaction | 0 | ||||||||||||||||||
non-cash interest expense | 615,000 | 773,000 | 768,000 | 761,000 | 763,000 | 767,000 | 766,000 | 753,000 | 757,000 | 761,000 | 776,000 | ||||||||
other | -4,790,000 | -3,545,000 | -2,539,000 | -1,609,000 | -343,000 | -943,000 | -974,000 | ||||||||||||
change in cash and restricted cash | 95,149,000 | 121,467,000 | -28,636,000 | -147,241,000 | 105,135,000 | 58,034,000 | -80,608,000 | -297,459,000 | -84,495,000 | ||||||||||
cash and restricted cash | |||||||||||||||||||
cash and restricted cash at beginning of period | 0 | 0 | 467,787,000 | 0 | 0 | 532,467,000 | 0 | 0 | 1,191,241,000 | 0 | |||||||||
cash and restricted cash at end of period | 95,149,000 | 121,467,000 | 439,151,000 | 105,135,000 | 58,034,000 | 451,859,000 | -84,495,000 | -98,273,000 | 1,012,694,000 | 554,228,000 | |||||||||
payments on beneficial interest assets | -1,173,000 | ||||||||||||||||||
change in fair value of financial instruments | 83,505,000 | 52,679,000 | 39,592,000 | 59,046,000 | 97,822,000 | 21,953,000 | 30,747,000 | 18,356,000 | 5,611,000 | -1,672,000 | -5,068,000 | 901,000 | |||||||
accounts payable | 5,572,000 | 87,000 | 384,000 | -12,170,000 | 8,432,000 | -11,633,000 | 11,708,000 | 3,371,000 | -2,957,000 | -7,936,000 | 9,187,000 | -5,807,000 | |||||||
acquisition, net of cash acquired | -196,000 | 0 | |||||||||||||||||
proceeds from secondary offering, net of underwriting discounts, commissions, and offering costs | 0 | 0 | |||||||||||||||||
payment of debt issuance costs | 0 | ||||||||||||||||||
cash and restricted cash at beginning of year | |||||||||||||||||||
cash and restricted cash at end of year | |||||||||||||||||||
residual certificates retained under unconsolidated securitization | |||||||||||||||||||
issuance of common stock in connection with acquisition | 0 | 0 | |||||||||||||||||
gain on loan servicing arrangement | -3,472,000 | -3,347,000 | -3,613,000 | -4,969,000 | -6,038,000 | -9,027,000 | -8,705,000 | ||||||||||||
purchase of loans held-for-sale | -826,388,000 | -740,343,000 | -510,003,000 | -6,347,901,000 | -333,763,000 | -682,575,000 | -443,190,000 | -138,823,000 | -41,994,000 | -20,071,000 | -18,240,000 | ||||||||
purchase of loans held-for-investment | -37,426,000 | -37,486,000 | -46,382,000 | -94,004,000 | -41,418,000 | -66,660,000 | -50,190,000 | -29,601,000 | -12,947,000 | ||||||||||
acquisition of beneficial interests | -13,078,000 | ||||||||||||||||||
purchase of non-marketable equity securities | |||||||||||||||||||
purchase of property and equipment | -135,000 | -39,000 | -1,111,000 | -1,737,000 | -1,510,000 | -3,949,000 | -1,629,000 | -3,471,000 | -2,959,000 | -1,730,000 | -267,000 | ||||||||
payments made on securitization notes | |||||||||||||||||||
beneficial interests included in payable to investors | 1,641,000 | ||||||||||||||||||
reclassification of loans | |||||||||||||||||||
net income before attribution to noncontrolling interests | 58,944,000 | 29,113,000 | 37,284,000 | 10,102,000 | |||||||||||||||
incentive share expense | |||||||||||||||||||
principal payments received for loans held by consolidated securitizations | |||||||||||||||||||
purchase of notes receivable and residual certificates | |||||||||||||||||||
proceeds from initial public offering, net of underwriting discounts and offering costs | |||||||||||||||||||
payments made on securitization notes and certificates | |||||||||||||||||||
distributions made to noncontrolling interests | |||||||||||||||||||
proceeds from exercise of convertible preferred stock warrants | |||||||||||||||||||
cash paid for amounts included in the measurement of lease liabilities | 3,117,000 | 3,197,000 | |||||||||||||||||
reclassification of common stock warrant liability related to cashless exercise | |||||||||||||||||||
reclassification of preferred stock warrant liability related to cash exercise | |||||||||||||||||||
reclassification of common stock warrant liability to equity upon termination of repurchase option | |||||||||||||||||||
purchase of loans for immediate resale | -722,080,000 | -1,782,442,000 | -3,014,594,000 | -2,840,488,000 | -2,458,757,000 | ||||||||||||||
proceeds from immediate resale of loans | 722,080,000 | 1,782,442,000 | 3,014,594,000 | 2,840,488,000 | 2,458,757,000 | ||||||||||||||
purchase of non-marketable equity security | 0 | 0 | -1,000,000 | ||||||||||||||||
net increase in cash and restricted cash | -178,547,000 | 19,480,000 | 554,228,000 | 281,467,000 | 24,733,000 | ||||||||||||||
reclassification of loans held-for-investment to held-for-sale | 109,792,000 | ||||||||||||||||||
gain on loan servicing arrangements and sale of noncontrolling interests | 67,000 | ||||||||||||||||||
gain on repurchased and retired convertible preferred stock warrants | |||||||||||||||||||
net proceeds from sale of loans held-for-sale | 22,032,000 | 33,354,000 | 19,043,000 | 38,140,000 | |||||||||||||||
net proceeds from sale of loans held-for-investment | 40,610,000 | 1,075,000 | 1,389,000 | 8,329,000 | |||||||||||||||
repayments of notes payable | |||||||||||||||||||
repurchase and retirement of convertible preferred stock warrants | |||||||||||||||||||
repurchase and retirement of convertible preferred stock | |||||||||||||||||||
proceeds from issuance of notes payable | |||||||||||||||||||
proceeds from issuance of convertible preferred stock, net of issuance costs | |||||||||||||||||||
derecognition of loans held-for-investment in consolidated vie | |||||||||||||||||||
derecognition of payable to securitization note holders and residual certificate holders | |||||||||||||||||||
derecognition of notes payable held in consolidated vie | |||||||||||||||||||
transfer of notes receivable and residual certificate on deconsolidation of vie | |||||||||||||||||||
gain on loan servicing arrangements | -2,121,000 | ||||||||||||||||||
noncash interest expense | 18,000 | ||||||||||||||||||
proceeds from issuance of convertible debt | |||||||||||||||||||
supplemental disclosures of non-cash operating activities | |||||||||||||||||||
total right-of-use assets capitalized | |||||||||||||||||||
purchase of loans for immediate resale to investors | -1,294,634,000 | ||||||||||||||||||
proceeds from immediate resale of loans to investors | 1,294,634,000 | ||||||||||||||||||
beginning of period | 311,333,000 | ||||||||||||||||||
end of period | 336,066,000 | ||||||||||||||||||
accrued interest on convertible notes | |||||||||||||||||||
purchase of loans held by consolidated securitizations | |||||||||||||||||||
proceeds from the issuance of securitization notes and certificates | |||||||||||||||||||
proceeds from sale of noncontrolling interests | |||||||||||||||||||
beginning of year | |||||||||||||||||||
end of year |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
